猪瘟兔化弱毒E2蛋白A／D区的高效表达和蛋白纯化及其应用

本试验对表达猪瘟E2囊膜糖蛋白的原核表达载体pET—E2的表达条件进行了优化,在此基础上,对表达的蛋白质进行了纯化。在6mol/L盐酸胍存在的条件下,将包涵体溶解在Tris-HCl中,并直接用于His Band亲和层析。收集过柱产物并透析,在2％SDS条件下,对所得的重组蛋白质进行了定量。重组蛋白质被用来包被96孔ELISA板并应用于免疫猪瘟抗体水平的测定。     

猪瘟兔化弱毒株E2基因的原核表达及间接ELISA的初步建立

猪瘟病毒E2蛋白C端含有一段30多个疏水性氨基酸组成的跨膜区域(Transmembraneregion,TMR),用RTPCR和巢式PCR分别扩增了含不同长度TMR的猪瘟兔化弱毒E2基因,并克隆入pGEX4T1的MCS中,构建了原核表达载体pGEXTE2339(无TMR)、pGEXTE2355(1TMR)、pGEXTE2375(3TMR)。因E2基因含有大量大肠杆菌稀有密码子,选择了BL21CodonPlus(DE3)RP作为表达受体菌,结果表明pGEXTE2339、pGEXTE2355以包涵体的形式正确表达了目的蛋白,而pGEXTE2375没有明显表达。并利用pGEXTE2339、pGEXTE2355表达的融合蛋白初步建立了间接ELISA方法。     

猪瘟兔化弱毒株E2基因的原核表达及间接ELISA的初步建立

猪瘟病毒E2蛋白C端含有一段30多个疏水性氨基酸组成的跨膜区域(Transmembrane region,TMR),用RT-PCR和巢式PCR分别扩增了含不同长度TMR的猪瘟兔化弱毒E2基因,并克隆入pGEX-4T-1的MCS中,构建了原核表达载体pGEXTE2-339(无TMR)、pGEXTE2-355(1TMR)、pGEXTE2-375(3TMR).因E2基因含有大量大肠杆菌稀有密码子,选择了BL21-CodonPlus(DE3)-RP作为表达受体菌,结果表明pGEXTE2-339、pGEXTE2-355以包涵体的形式正确表达了目的蛋白,而pGEXTE2-375没有明显表达.并利用pGEXTE2-339、pGEXTE2-355表达的融合蛋白初步建立了间接ELISA方法.     

猪瘟病毒E0蛋白的原核表达及其间接ELISA方法的建立

表达猪瘟病毒保护性抗原E0蛋白用以建立猪瘟抗体诊断方法,在标记疫苗(Marker vaccine)的研制和应用上具有重要的血清学鉴别功能,对于监测猪瘟病毒的流行情况和疫苗免疫情况及制定免疫程序具有重要作用.将猪瘟兔化弱毒株(HCLV)E0基因分别插入原核表达质粒pGEX4T,pET30,pMAL-p2X中,并分别以BL21和BL21-codonplus(DE3)-RP, BL21(DE3)和BL21-codonplus(DE3)-RP,TB1和BL21-codonplus(DE3)-RP为表达菌株.通过摸索IPTG诱导浓度,诱导温度,菌体收获时间,确定E0基因能在pGEX4T/ BL21-codonplus(DE3)-RP和pMAL-p2X/ BL21-codonplus(DE3)-RP中获得高效表达,表达产量分别占菌体总蛋白的15%和30%,表达的重组蛋白主要为包涵体形式.分别采用B-per试剂和超声波裂解配以曲通尿素对包涵体进行洗涤两种方法在pGEX表达系中取得了较好的效果.使用分步透析法对变性的包涵体进行复性,将复性蛋白过GST亲和层析柱得到纯化的GST-E0融合蛋白.以GST-E0融合蛋白为诊断抗原,通过摸索抗原包被浓度,抗体血清稀释倍数初步建立了用间接ELISA检测猪瘟血清E0抗体的方法,为进一步开发猪瘟抗体检测试剂盒奠定基础.     

猪瘟病毒E0蛋白的原核表达及其间接ELISA方法的建立

表达猪瘟病毒保护性抗原E0蛋白用以建立猪瘟抗体诊断方法,在标记疫苗(Marker vaccine)的研制和应用上具有重要的血清学鉴别功能,对于监测猪瘟病毒的流行情况和疫苗免疫情况及制定免疫程序具有重要作用.将猪瘟兔化弱毒株(HCLV)E0基因分别插入原核表达质粒pGEX4T,pET30,pMAL-p2X中,并分别以BL21和BL21-codonplus(DE3)-RP, BL21(DE3)和BL21-codonplus(DE3)-RP,TB1和BL21-codonplus(DE3)-RP为表达菌株.通过摸索IPTG诱导浓度,诱导温度,菌体收获时间,确定E0基因能在pGEX4T/ BL21-codonplus(DE3)-RP和pMAL-p2X/ BL21-codonplus(DE3)-RP中获得高效表达,表达产量分别占菌体总蛋白的15%和30%,表达的重组蛋白主要为包涵体形式.分别采用B-per试剂和超声波裂解配以曲通尿素对包涵体进行洗涤两种方法在pGEX表达系中取得了较好的效果.使用分步透析法对变性的包涵体进行复性,将复性蛋白过GST亲和层析柱得到纯化的GST-E0融合蛋白.以GST-E0融合蛋白为诊断抗原,通过摸索抗原包被浓度,抗体血清稀释倍数初步建立了用间接ELISA检测猪瘟血清E0抗体的方法,为进一步开发猪瘟抗体检测试剂盒奠定基础.     

中国猪瘟兔化弱毒兔脾毒NS2-3基因的序列分析

根据已发表的猪瘟病毒序列,设计并合成了覆盖有ＮＳ２－３全基因的４上物,应用ＲＴ－ＰＣＲ技术从接种了猪瘟兔化弱毒（ｈｏｇ ｃｈｏｌｅｒａ ｖｉｒｕｓ ｌａｐｉｎｉｚｅｄ Ｃｈｉｎｅｓｅ ｓｔｒａｉｎ,ＨＣＬＶ）的兔脾组织中,成功地扩增了ＮＳ２－３基因,将其克隆到Ｔ载体后,测定了其核苷酸序列。结果显示,所克隆的ＮＳ２－３基因长２９６４个核苷酸,编码９８８年氨基酸。用ＤＮＡＳＩＳ和ＰＲＯＳＩＳ软件分析表     

猪瘟病毒石门强毒株和兔化弱毒疫苗株E2蛋白糖基化位点差异分析

猪瘟病毒强毒株和兔化弱毒疫苗株E2糖蛋白分别含有5个和6个潜在的糖基化位点,其中986N是兔化弱毒疫苗株所特有的。为了分析二者糖基化位点差异及其影响,将去掉信号肽和跨膜区的猪瘟病毒石门强毒株(Shi-men)和兔化弱毒疫苗株(HCLV)E2基因置于蜂素信号肽序列下游,使其在Sf9细胞内表达重组Shimen-E2和HCLV-E2蛋白。结果显示,重组E2蛋白以二聚体的形式分泌表达于细胞培养液中,但二者分子量存在差异。用endo H和PNGase F对纯化后的重组E2蛋白进行去糖基化处理后,二者分子量大小变成一致,证实石门强毒株和兔化弱毒株E2蛋白分子量大小的差异可能是由于糖基化程度的差异所致。对986N糖基化位点进行定点突变后发现,突变后的Shimen-E2与野生型HCLV-E2分子量大小一致,而突变后的HCLV-E2与野生型Shimen-E2分子量大小一致,表明Shimen-E2和HCLV-E2分子量大小的差异的确是由于986N糖基化位点的差异引起的。     

建立快速定量检测猪瘟兔化弱毒苗的荧光定量PCR技术

在猪瘟病毒兔化弱毒疫苗株的5’非编码区设计一对引物和一条荧光探针,利用荧光定量PCR原理,结合LightCycler检测系统,首次建立了定量检测猪瘟兔化弱毒苗方法。结果表明,该方法的灵敏度为10^2拷贝数,线性范围为10^7—10^2,达6个数量级;标准样品的变异系数为2．3％—5．1％(n＝10),疫苗样品组内实验变异系数为0．85％—2．8％(n＝5)、组间实验为2．5％—7．3％(n＝5),对同一样品分5次RNA提取和逆转录,其变异系数为5．0％;对9份疫苗样品进行了检测,与免体定型热反应方法相比较,有很好的相关性;整个检测过程仅需4h。该法可望取代传统的兔体定型热反应用于疫苗生产过程中的效价测定及指导疫苗的配制,也为猪瘟病毒分子生物学研究提供了一种新的、简捷有效的工具。     

含CSFV E2基因A/D区原核表达载体的构建、表达及其抗原性研究

应用RT PCR方法扩增了编码猪瘟病毒石门株 (CSFVshimenstrain)囊膜糖蛋白E2全基因 ,然后将其克隆到pMD 1 8T质粒中 ,获得重组质粒pMD E2。再以pMD E2为模板 ,另行设计两对引物 ,同时扩增其中一段适于在E .coli中表达且抗原反应性较好的基因片段 (E2蛋白A D抗原区基因序列 ) ,将扩增的两片段串联插入原核表达载体pET 32a中构建成重组质粒pET 2e。用酶切和序列分析鉴定插入目的基因的正确性。SDS PAGE和Western blot分析表明 ,经pET 2e转化、IPTG诱导的受体菌可表达目的蛋白 ,克隆在硫氧还蛋白 (thioredoxinprotein ,TrxA)基因下游的E2蛋白基因与TrxA基因获得了高效融合表达 ,并且具有免疫学反应活性 ,这为猪瘟的血清学诊断方法的建立打下了基础 。     

NMDAR1蛋白膜外抗原结构域的重组表达、纯化和免疫反应原性鉴定

构建编码NMDAR1蛋白膜外片段的原核表达重组质粒,在大肠杆菌中诱导表达、纯化并鉴定其免疫反应原性。根据人NMDAR1基因序列,利用Phyre 2软件预测蛋白的三级结构并分析其结构域。设计引物用RT-PCR方法扩增编码NMDAR1膜外蛋白不同结构域的核酸片段,并插入原核表达载体pCold-SUMO构建重组质粒。转化DH5α感受态细胞,菌落PCR鉴定,阳性单克隆进行测序验证。鉴定正确的重组体转化大肠杆菌BL21(DE3),IPTG诱导目的蛋白的表达和纯化,Ni-NTA柱亲和层析和凝胶过滤层析纯化蛋白,酶切切除融合蛋白6His-SUMO标签,用AKTA Purifier进行凝胶过滤层析,收集纯化蛋白。利用SDS-PAGE鉴定蛋白纯度,并用Western blotting进行免疫反应性鉴定。克隆获得NMDAR1膜外部分的三段DNA序列,分别是NR1-M1(编码19–393 aa)、NR1-S1(编码394–544 aa)和NR1-S2(编码663–800 aa)。其中NR1-S1和NR1-S2片段之间以G(甘氨酸)和T(苏氨酸)作为接头连接成为复合片段。经菌落PCR筛选和测序鉴定,成功构建了重组质粒p Cold-SUMO-M1和p Cold-SUMO-S1-GT-S2。SDS-PAGE鉴定结果表明重组质粒在大肠杆菌中经诱导可表达可溶性NR1-M1及NR1-S1-GT-S2蛋白。对表达产物进行亲和层析和凝胶过滤层析获得了高纯度的目标蛋白。Western blotting证实纯化的目的蛋白能与相应抗体发生特异性结合反应。本研究成功构建了NMDAR1蛋白膜外抗原结构域的原核表达系统,并获得了具有免疫反应性的NR1-M1及NR1-S1-GT-S2纯化蛋白。该蛋白有望用于NMDAR1蛋白的功能研究及自身抗体的检测。     

猪细小病毒VP2蛋白主要抗原域间接ELISA方法的建立及初步应用

将已获得的含猪细小病毒VP2蛋白主要抗原域编码基因VP2I重组酵母菌株在优化的条件下进行诱导表达,表达产物蛋白含量达227.6μg/mL,在此基础上以重组蛋白作为包被抗原初步建立了检测猪细小病毒抗体水平的间接ELISA方法,并对该方法进行了优化,结果表明抗原最佳包被浓度5.69μg/mL,而血清最佳稀释倍数为1:80。阳性标准初步定为：OD待测样品＞0.5,且OD待测样品/OD阴性血清＞2.0。采用iVP2I-ELISA对猪血清样品进行检测,结果显示iVP2I-ELISA与HI试验的符合率为97.2%,与国外同类试剂盒的符合率达到91.2%。     

Expression and purification of His-tagged HPV16 E7 protein active in pRb binding

Human papillomavirus type 16 (HPV16) protein E7 is the major oncogenic factor associated with the development of human cervical cancer. The transforming activity of the E7 protein is linked to its interaction with host regulatory proteins such as the retinoblastoma tumor suppressor protein. The recombinant production of E7 protein is a prerequisite for its structural and functional characterization as well as for the development of various preventive and therapeutic strategies. We present an approach to enhance the soluble expression of His-tagged E7 protein by optimization of the E7 gene and the expression conditions in the host Escherichia coli. We also report a detailed protocol for the purification of E7 protein by standard chromatographic methods. The binding of E7 protein to the recombinant non-phosphorylated form of retinoblastoma protein was examined by ELISA and surface plasmon resonance analysis. These studies confirm that the recombinant His-tagged E7 protein retains its conformational properties and biological activity.     

GST-Ccd1融合蛋白的表达、纯化及多克隆抗体制备

目的：利用大肠杆菌DH5α表达GST—Ccd1融合蛋白,并用亲和层析分离纯化,进行动物免疫制备多克隆抗体。方法：利用本室构建好的pGEX-5X-1-Ccd1-N原核表达重组质粒,转化大肠杆菌DH5α,经IPTG诱导表达,在大肠杆菌表达系统中获得可溶性表达。经谷胱甘肽Sepharose 4B介质填充的层析柱分离纯化蛋白,制备抗原免疫动物,得到Ccd1的兔源多克隆抗体。结果：ELISA结果显示血清抗体效价可以达到1∶40 000。免疫组化分析表明自制的抗体能特异性与Ccd1蛋白相互作用,可以用于实验分析。结论：制备了效价高特异性良好的抗Ccd1多克隆抗体,经实验验证获得的抗体能够满足针对Ccd1的免疫印迹和免疫组化检测的实验要求,为今后深入研究Ccd1表达的组织分布、细胞内定位及其生物学功能提供了有用的实验工具。     

Persistence of specific antigenic protein in the serum of chickens given intravenously botulinum toxin type B, C, D, E or F

A sublethal dose of Clostridium botulinum progenitor toxin of each of types B, C, D, E, and F was injected once intravenously into chickens. Blood samples were withdrawn periodically from the chickens to determine the toxin remaining in the serum by the mouse injection test and by enzyme-linked immunosorbent assay (ELISA) for both toxic and nontoxic components composing the progenitor toxin. Both components were detected by ELISA for at least a few days after the serum had became innocuous to mice, indicating a higher stability of the antigenicities of both components than the lethal toxicity in the chicken serum. For the diagnosis of botulism, it seems justified to recommend detection of the antigen (toxic component or nontoxic component or both) by ELISA even if no toxin is detected by the mouse test. Such immunological tests would no doubt contribute to an increase in the rate of diagnosis of human and animal botulism cases, particularly when blood sampling is delayed.     

Expression screening,protein purification and NMR analysis of human protein domains for structural genomics

Structural genomics, the determination of protein structures on a genome-wide scale, is still in its infancy for eukaryotes due to the number and size of their genes. Low protein expression and solubility of eukaryotic geneproducts are the major bottlenecks in high-throughput (HTP) recombinant protein production with the E. coli expression systems. To circumvent this problem we decided to focus on separate protein domains. We describe here a fast microtiterplate based, expression and solubility screening procedure, using a combination of in vitro and in vivo expression, and purification with nickel-NTA magnetic beads. All steps are optimized for automatic HTP processing using a liquid handling station. Furthermore, large-scale expression and protein purification conditions are optimized, permitting the purification of 24 protein samples per week. We further show that results obtained from the expression screening can be extrapolated to the production of protein samples for NMR. Starting with 81 cloned human protein domains, in vivo expression was detected in 54 cases, and from 28 of those milligrams of protein were purified. An informative HSQC spectrum was recorded for 18 proteins (22%), half of which were indicative of a folded protein. The success rate and quality of the HSQC spectra suggest that the domain approach holds promise for human proteins.     

HCV的Core-NS3嵌合抗原在大肠杆菌中的表达、纯化及初步应用

用已经构建的含有HCV的Core-NS3(C33 c)嵌合基因的表达质粒pGEX TL1-2在大肠杆菌中进行了高效表达,表达产物纯化后通过SDS-PAGE、W estern-b lot、ELISA等一系列鉴定试验进行了分析,结果表明,该嵌合抗原具有高度特异性和良好的抗原活性,为研制诊断用HCV抗原奠定基础。     

Expression, purification and antimicrobial activity of puroindoline A protein and its mutants

Wheat puroindoline proteins, PINA and PINB, play key roles in determining wheat grain hardness as well as in defending the plant against pathogens. PINA has much greater membrane-binding property and antimicrobial activity because it contains more tryptophan residues in the unique tryptophan-rich domain (TRD). In order to obtain proteins with higher antimicrobial activity, mutants of PINA containing two or three copies of TRD, designated ABBC and ABBBC, respectively, were constructed and expressed in E. coli Rosetta-gami (DE3). Metal affinity chromatography was used to purify the soluble affinity-tagged recombinant proteins. The secondary structures of the recombinant proteins were predicted by the online program Protein Homology/analog Y Recognition Engine v2.0 and experimentally assessed using circular dichroism. Minimum inhibition concentration tests and fluorescence microscope analyses were employed to evaluate the antimicrobial activities of the mutants. The results showed that the purified recombinant ABBC was correctly folded and presented significantly higher antimicrobial activities against E. coli and S. aureus than wild-type PINA, suggesting its potential use as an antimicrobial agent. The results also confirmed that TRD is a determinant of the antimicrobial activity of PINA and demonstrated that it is feasible to enhance the antimicrobial activity of PINA by adding one copy of TRD.     

Expression, purification, crystallization and preliminary x-ray analysis of Cyan fluorescent protein CyPet

The technique of fluorescence (or F?rster) resonance energy transfer (FRET) is widely used to observe bimolecular interaction in living cells. Cyan and yellow fluorescent proteins are the most widely used pair in FRET analysis. CyPet and YPet are two newly optimized fluorescent proteins that have much better dynamic range and sensitivity than CFP/YFP pair, although the crystallographic structure and the mechanism of better fluorescent characteristics of CyPet are still unknown. We have expressed the cyan fluorescent protein CyPet using pT7 prokaryocyte expression system in Escherichia coli strain Rosetta (DE3) pLysS by auto-induction. After purification, the recombinant CyPet protein was crystallized by hanging drop vapor diffusion technique and could diffract to 2.55A resolution. The data showed that the orthorhombic CyPet crystal was in space group P212121 with unit cell parameters (51.55, 61.53, 63.36) and contained one molecule in one asymmetric unit.